Health Care & Life Sciences » Pharmaceuticals | Il Dong Pharmaceutical Co. Ltd.

Il Dong Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2014
2015
2016
2017
2018
Sales/Revenue
417,517
476,385
201,344
460,651
503,907
Cost of Goods Sold (COGS) incl. D&A
211,574
239,740
106,448
240,660
259,798
Gross Income
205,943
236,645
94,895
219,991
244,110
SG&A Expense
191,481
212,918
80,103
194,630
216,955
EBIT
14,462
23,727
14,792
25,361
27,155
Unusual Expense
-
-
-
2,141
7,771
Non Operating Income/Expense
1,130
2,407
887
699
234
Interest Expense
6,952
5,351
1,724
3,751
3,588
Pretax Income
9,805
21,903
14,014
20,422
16,438
Income Tax
2,443
941
1,436
581
3,717
Equity in Affiliates
312
369
-
-
-
Consolidated Net Income
11,935
21,331
12,579
19,841
12,721
Net Income
11,856
20,979
12,579
19,841
12,721
Net Income After Extraordinaries
11,856
20,979
12,579
19,841
12,721
Net Income Available to Common
11,856
20,979
12,579
19,841
12,721
EPS (Basic)
548.76
971.59
640.91
1,011.00
561.36
Basic Shares Outstanding
22
22
20
20
23
EPS (Diluted)
549.06
971.59
640.93
1,011.16
561.36
Diluted Shares Outstanding
22
22
20
20
23
EBITDA
-
-
22,291
43,807
50,755
Non-Operating Interest Income
1,164
1,119
59
254
408
Minority Interest Expense
79
351
-
-
-

About Il Dong Pharmaceutical Co.

View Profile
Address
2 Baumoe-ro 27-gil
Seoul SL 06752
Korea, Republic Of
Employees -
Website http://www.ildong.com
Updated 07/08/2019
Ildong Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include vitamins, antibiotics, medicines for diabetes. gastruc ulcer, and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.